Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 12월 2023 - 10:30PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer,
Chairman, President and Chief Executive Officer, will present an
update on the company at the 42nd annual J.P. Morgan Healthcare
Conference on January 8, 2024.
The live presentation is scheduled to begin at approximately
12:45 PM EST and will be concurrently webcast.
Links to the webcast will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring systems.
Headquartered in San Diego, Calif., and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom works to simplify and
improve diabetes management around the world. For more information
on Dexcom, visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219445271/en/
DexCom, Inc. Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024